Abstract
TheStreptococcus milleri group is associated with a spectrum of serious suppurative infections that have not been well defined. The purposes of this study were to ascertain the clinical significance ofStreptococcus milleri bacteremia and to determine the epidemiological, clinical, and microbiological features of these infections compared to those caused by other viridans streptococci. All cases of streptococcal bacteremia observed in a Spanish hospital in the period from January 1988 to December 1994 were reviewed. Of 137 cases ofStreptococcus milleri infection, 33 (24%) were documented cases of bacteremia. Twenty-four patients were men (mean age 57.8 ± 17.4 years). The majority of infections were abdominal in origin (20/33), the most frequent diagnoses being cholangitis/cholecystitis (18%) and appendicitis (12%). The origin of infection could not be established in three cases. Nine cases of bacteremia (27%) were polymicrobial. Six patients (18%) had septic shock; in four the infection was polymicrobial, and in two the infection was of abdominal origin. Eighteen of the 33 patients (54%) required surgery. Five patients died. All 33Streptococcus milleri isolates were susceptible to penicillin. Twenty-two cases of bacteremia caused by other viridans streptococci were observed during the same period. There were no statistically significant differences between the two groups in terms of age, sex, mortality, rate of polymicrobial infection, rate of nosocomial acquisition of bacteremia, or the occurrence of shock. An abdominal origin of infection was more frequent inStreptococcus milleri bacteremia (p=0.0001); a cardiovascular origin was more frequent in the viridans group (p=0.01), as was a diagnosis of endocarditis (p=0.004). Four patients with viridans streptococci bacteremia required surgery versus 18 patients withStreptococcus milleri bacteremia (p=0.01). Viridans streptococci were notably less susceptible to penicillin (89%), clindamycin (79%), and erythromycin (79%).
Similar content being viewed by others
References
Whiley RA, Fraser H, Hardie JM, Beighton D: Phenotypic differentiation ofStreptococcus intermedius, Streptococcus constellatus, andStreptococcus anginosus strains within the “Streptococcus milleri group”. Journal of Clinical Microbiology 1990, 28: 1497–1501.
Gossling J: Occurrence and pathogenicity of theStreptococcus milleri group. Reviews of Infectious Diseases 1988, 10: 257–285.
Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH:Streptococcus milleri group: renewed interest in an elusive pathogen. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 491–498.
Skerman VBD, McGowan V, Sneath PHA: Approved lists of bacterial names. International Journal of Systematic Bacteriology 1980, 30: 225–420.
Fernández B, de Quirós J, Telenti M, Moreno A, Arroyo F: Infecciones clínicas porStreptococcus intermedius. Revista Clínica Española 1988, 183: 227–231.
Esteban A, Villuendas NC, López C, Marco ML, Moles B, Aldea MJ, Aísa ML: Infecciones producidas porStreptococcus milleri. Revista Española de Microbiología Clínica 1991, 6: 387–392.
Molina F, Durán MT: Características microbiológicas y espectro de infecciones de 108Streptococcus anginosus aislados. Enfermedades Infecciosas y Microbiología Clinica 1993, 11: 304–308.
Murray HW, Gross KC, Masur H, Roberts RB: Serious infections caused byStreptococcus milleri. American Journal of Medicine 1978, 64: 759–764.
Molina JM, Leport C, Bura A, Wolff M, Michon C, Vilde JL: Clinical and bacterial features of infections caused byStreptococcus milleri. Scandinavian Journal of Infectious Diseases 1991, 23: 659–666.
Editorial:Streptococcus milleri, pathogen in various guises. Lancet 1985, ii: 1403–1404.
Colman G, Williams REO: Taxonomy of some human viridans streptococci. In: Wannamaker LW, Matsen JM (ed): Streptococci and streptococcal diseases: recognition, understanding, and management. Academic Press, New York, 1972, p. 281–299.
Summanen P: Recent taxonomic changes for anaerobic gram-positive and selected gram-negative organisms. Clinical Infectious Diseases 1993, 16, Supplement 4: 168–174.
Ruoff KL:Streptococcus anginosus (“Streptococcus milleri”): the unrecognized pathogen. Clinical Microbiology Reviews 1988, 1: 102–108.
Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB: Bacteremia involving the “Streptococcus milleri” group: analysis of 19 cases. Clinical Infectious Diseases 1994, 19: 704–713.
Van der Auwera P: Clinical significance ofStreptococcus milleri. European Journal of Clinical Microbiology 1985, 4: 386–390.
Shlaes DM, Lerner PI, Wolinsky E, Gopalakrisna KV: Infections due to Lancefield group F and related streptococci (Streptococcus milleri, Streptococcus anginosus). Medicine 1981, 60: 197–207.
Chua D, Reínhart HH, Sovel JD: Liver abscess caused byStreptococcus milleri. Reviews of Infectious Diseases 1989, 11: 197–202.
Hocken DB, Dussek JE:Streptococcus milleri as a cause of pleural empyema. Thorax 1985, 40: 626–628.
Brook MG, Lucas RE, Pain AK: Clinical features and management of two cases ofStreptococcus milleri chest infections. Scandinavian Journal of Infectious Diseases 1988, 20: 345–346.
Cox RA, Chen K, Coykendall AL, Wesbecker P, Henson VC: Fatal infection in neonates of 26 weeks gestation due toStreptococcus milleri: report of two cases. Journal of Clinical Pathology 1987, 40: 190–193.
Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM:Streptococcus intermedius, Streptococcus constellatus, andStreptococcus anginosus (theStreptococcus milleri group): association with different body sites and clinical infections. Journal of Clinical Microbiology 1992, 30:243–244.
Le Pennec MP, Berardi-Grassias L: In vitro activity of 13 antibiotics against clinical isolates ofStreptococcus milleri. Journal of Antimicrobial Chemotherapy 1989, 24: 618–619.
Tillotson GS, Ganguli LA: Antibiotic susceptibilities of clinical strains ofStreptococcus milleri and related streptococci. Journal of Antimicrobial Chemotherapy 1984, 14: 557–560.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salavert, M., Gomez, L., Rodriguez-Carballeira, M. et al. Seven-year review of bacteremia caused byStreptococcus milleri and other viridans streptococci. Eur. J. Clin. Microbiol. Infect. Dis. 15, 365–371 (1996). https://doi.org/10.1007/BF01690091
Issue Date:
DOI: https://doi.org/10.1007/BF01690091